FindTrial
Sign In

A multicenter cross-sectional study of acute angle closure glaucoma outbreaks during the COVID-19 pandemic in China

A multicenter cross-sectional study of acute angle closure glaucoma outbreaks during the COVID-19 pandemic in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068768
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute angle closure glaucoma

Interventions

Group of acute angle closure glaucoma:None

Sponsors

The Eye of Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Inpatients diagnosed as acute angle-closure glaucoma (the hospitalization period is from September 7, 2020 to January 7, 2021, September 7, 2021 to January 7, 2022 and September 7, 2022 to January 17, 2023); (2) Age = 18

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

MeasureTime frame
age;gender;General vital signs;Personal history;Eye history;History of COVID-19;Systemic history;—

Countries

china

Contacts

Public ContactYuanbo Liang

The Eye of Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University

yuanboliang@126.com+86 18257748686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026